Saltz, I distinctly remember hearing that Patterson/IncellDx wanted five times as much money to do the data analysis of the Phase 2 trial as the company that Nader decided to go with. So Nader was thinking of what would be in the best interests of shareholders as he has repeatedly claimed is his main motivation. I don't remember the source of that information, but I believe that it is more or less true.
If Patterson wants top dollar for his services, we'll be contracting with others.
News 
Market Data 
Discover 
